{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Unnamed: 0.1</th>\n",
       "      <th>Unnamed: 0</th>\n",
       "      <th>NCT_NUMBER</th>\n",
       "      <th>STUDY_TITLE</th>\n",
       "      <th>STUDY_URL</th>\n",
       "      <th>STUDY_STATUS</th>\n",
       "      <th>CONDITIONS</th>\n",
       "      <th>PHASES</th>\n",
       "      <th>LOCATIONS</th>\n",
       "      <th>START_DATE</th>\n",
       "      <th>...</th>\n",
       "      <th>MAXIMUMAGE</th>\n",
       "      <th>POINT_OF_CONTACT</th>\n",
       "      <th>PHASE</th>\n",
       "      <th>SEX</th>\n",
       "      <th>ELIGIBILITY_CRITERIA</th>\n",
       "      <th>PRIMARY_OUTCOMES</th>\n",
       "      <th>SECONDARY_OUTCOMES</th>\n",
       "      <th>INTERVENTIONS</th>\n",
       "      <th>STUDY_TYPE</th>\n",
       "      <th>ENROLLMENT</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>NCT03275311</td>\n",
       "      <td>Evolution of the Therapeutic Care in Metastati...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT03275311</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>['Metastatic Breast Cancer']</td>\n",
       "      <td>NaN</td>\n",
       "      <td>[{'Location Facility': \"Institut de Cancérolog...</td>\n",
       "      <td>2014-07</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>Eligibility includes patients who are 18 years...</td>\n",
       "      <td>The primary outcome is to describe the evoluti...</td>\n",
       "      <td>Secondary outcomes aim to describe the impact ...</td>\n",
       "      <td>The study does not specify interventions as it...</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>38000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>NCT06150898</td>\n",
       "      <td>Ketorolac and Pregabalin Effects on breaSt Can...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT06150898</td>\n",
       "      <td>NOT_YET_RECRUITING</td>\n",
       "      <td>['Early-stage Breast Cancer', 'Estrogen-recept...</td>\n",
       "      <td>['PHASE2']</td>\n",
       "      <td>[{'Location Facility': 'Imane Bachir', 'Locati...</td>\n",
       "      <td>2024-02-20</td>\n",
       "      <td>...</td>\n",
       "      <td>70 Years</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>FEMALE</td>\n",
       "      <td>Eligibility includes women aged 18-70 with a w...</td>\n",
       "      <td>Primary outcomes focus on the perioperative pe...</td>\n",
       "      <td>Secondary outcomes include changes in anxiety ...</td>\n",
       "      <td>The study involves four experimental arms: no ...</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>112</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>2</td>\n",
       "      <td>2</td>\n",
       "      <td>NCT06214793</td>\n",
       "      <td>Taletrectinib in Previously Treated Metastatic...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT06214793</td>\n",
       "      <td>NOT_YET_RECRUITING</td>\n",
       "      <td>['Breast Cancer', 'Metastatic Breast Cancer']</td>\n",
       "      <td>['PHASE2']</td>\n",
       "      <td>[{'Location Facility': 'Marone Cancer Center C...</td>\n",
       "      <td>2024-10-01</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>Eligibility includes individuals 18 years or o...</td>\n",
       "      <td>The primary outcome measure is the Objective R...</td>\n",
       "      <td>Secondary outcomes include Progression Free Su...</td>\n",
       "      <td>The intervention involves administering Taletr...</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>61</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>3</td>\n",
       "      <td>3</td>\n",
       "      <td>NCT05496101</td>\n",
       "      <td>CLI and FAR for Intraoperative Margin Assessment</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT05496101</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>['Breast Cancer Female']</td>\n",
       "      <td>['PHASE2']</td>\n",
       "      <td>[{'Location Facility': \"Guy's and St Thomas NH...</td>\n",
       "      <td>2022-11-21</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>FEMALE</td>\n",
       "      <td>Eligibility includes female subjects aged 18 o...</td>\n",
       "      <td>The primary outcome is the margin status of wi...</td>\n",
       "      <td>Secondary outcomes include the agreement betwe...</td>\n",
       "      <td>The intervention involves intraoperative Ceren...</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>60</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>4</td>\n",
       "      <td>4</td>\n",
       "      <td>NCT05935384</td>\n",
       "      <td>SIBYL: obServation of Therapy Response With lI...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT05935384</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>['Non-small Cell Lung Cancer', 'Colorectal Can...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>[{'Location Facility': 'Orchard Healthcare Res...</td>\n",
       "      <td>2023-10-25</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>Eligibility includes patients who will be trea...</td>\n",
       "      <td>The primary outcome is the sensitivity of ctDN...</td>\n",
       "      <td>Secondary outcomes include RECIST v1.1 respons...</td>\n",
       "      <td>Interventions involve the collection of blood ...</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>440</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2524</th>\n",
       "      <td>2524</td>\n",
       "      <td>2524</td>\n",
       "      <td>NCT06327490</td>\n",
       "      <td>A Study Evaluating the Feasibility and Complia...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT06327490</td>\n",
       "      <td>NOT_YET_RECRUITING</td>\n",
       "      <td>['Breast Cancer']</td>\n",
       "      <td>['NA']</td>\n",
       "      <td>[{'Location Facility': 'University of Florida'...</td>\n",
       "      <td>2024-06</td>\n",
       "      <td>...</td>\n",
       "      <td>99 Years</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>Eligibility includes adults ≥18 years undergoi...</td>\n",
       "      <td>The primary outcome is to determine subject co...</td>\n",
       "      <td>Secondary outcomes include comparing relative ...</td>\n",
       "      <td>The study compares two types of manual lymphat...</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>30</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2525</th>\n",
       "      <td>2525</td>\n",
       "      <td>2525</td>\n",
       "      <td>NCT04314401</td>\n",
       "      <td>National Cancer Institute \"Cancer Moonshot Bio...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT04314401</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>['Acute Myeloid Leukemia', 'Anatomic Stage III...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>[{'Location Facility': 'Kingman Regional Medic...</td>\n",
       "      <td>2020-11-11</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>Eligibility includes patients diagnosed or con...</td>\n",
       "      <td>The primary outcomes involve procuring, storin...</td>\n",
       "      <td>Secondary outcomes focus on pan-cancer gene pa...</td>\n",
       "      <td>Interventions include the collection of tissue...</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>1000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2526</th>\n",
       "      <td>2526</td>\n",
       "      <td>2526</td>\n",
       "      <td>NCT04472845</td>\n",
       "      <td>HYPofractionated Adjuvant RadioTherapy in 1 Ve...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT04472845</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>['Breast Cancer', 'Hypofractionation', 'Radiot...</td>\n",
       "      <td>['NA']</td>\n",
       "      <td>[{'Location Facility': 'Budhi Singh Yadav', 'L...</td>\n",
       "      <td>2021-03-30</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>FEMALE</td>\n",
       "      <td>Eligibility includes individuals aged 18 or ol...</td>\n",
       "      <td>The primary outcome measure is loco-regional r...</td>\n",
       "      <td>Secondary outcomes include disease-free surviv...</td>\n",
       "      <td>The study involves two arms: the experimental ...</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>1018</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2527</th>\n",
       "      <td>2527</td>\n",
       "      <td>2527</td>\n",
       "      <td>NCT05536128</td>\n",
       "      <td>Evaluating the Efficacy and Safety of Fulvestr...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT05536128</td>\n",
       "      <td>NOT_YET_RECRUITING</td>\n",
       "      <td>['Advanced Breast Cancer']</td>\n",
       "      <td>['PHASE2']</td>\n",
       "      <td>[{'Location Facility': 'Seoul National Univers...</td>\n",
       "      <td>2022-12-31</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>Eligibility includes adults 19+ with HR+/HER2-...</td>\n",
       "      <td>The primary outcome is the 6-month progression...</td>\n",
       "      <td>Secondary outcomes include progression-free su...</td>\n",
       "      <td>The study involves administering Olaparib tabl...</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>64</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2528</th>\n",
       "      <td>2528</td>\n",
       "      <td>2528</td>\n",
       "      <td>NCT05403554</td>\n",
       "      <td>A Study of NI-1801 in Patients With Mesothelin...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT05403554</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>['Epithelial Ovarian Cancer', 'Triple Negative...</td>\n",
       "      <td>['PHASE1']</td>\n",
       "      <td>[{'Location Facility': 'Institut Curie', 'Loca...</td>\n",
       "      <td>2022-04-29</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>Eligibility includes adults ≥18 years with his...</td>\n",
       "      <td>Primary outcomes focus on safety and dosage, i...</td>\n",
       "      <td>Secondary outcomes measure efficacy and pharma...</td>\n",
       "      <td>The intervention involves administering NI-180...</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>40</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>2529 rows × 22 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "      Unnamed: 0.1  Unnamed: 0   NCT_NUMBER  \\\n",
       "0                0           0  NCT03275311   \n",
       "1                1           1  NCT06150898   \n",
       "2                2           2  NCT06214793   \n",
       "3                3           3  NCT05496101   \n",
       "4                4           4  NCT05935384   \n",
       "...            ...         ...          ...   \n",
       "2524          2524        2524  NCT06327490   \n",
       "2525          2525        2525  NCT04314401   \n",
       "2526          2526        2526  NCT04472845   \n",
       "2527          2527        2527  NCT05536128   \n",
       "2528          2528        2528  NCT05403554   \n",
       "\n",
       "                                            STUDY_TITLE  \\\n",
       "0     Evolution of the Therapeutic Care in Metastati...   \n",
       "1     Ketorolac and Pregabalin Effects on breaSt Can...   \n",
       "2     Taletrectinib in Previously Treated Metastatic...   \n",
       "3      CLI and FAR for Intraoperative Margin Assessment   \n",
       "4     SIBYL: obServation of Therapy Response With lI...   \n",
       "...                                                 ...   \n",
       "2524  A Study Evaluating the Feasibility and Complia...   \n",
       "2525  National Cancer Institute \"Cancer Moonshot Bio...   \n",
       "2526  HYPofractionated Adjuvant RadioTherapy in 1 Ve...   \n",
       "2527  Evaluating the Efficacy and Safety of Fulvestr...   \n",
       "2528  A Study of NI-1801 in Patients With Mesothelin...   \n",
       "\n",
       "                                             STUDY_URL        STUDY_STATUS  \\\n",
       "0     https://www.clinicaltrials.gov/study/NCT03275311          RECRUITING   \n",
       "1     https://www.clinicaltrials.gov/study/NCT06150898  NOT_YET_RECRUITING   \n",
       "2     https://www.clinicaltrials.gov/study/NCT06214793  NOT_YET_RECRUITING   \n",
       "3     https://www.clinicaltrials.gov/study/NCT05496101          RECRUITING   \n",
       "4     https://www.clinicaltrials.gov/study/NCT05935384          RECRUITING   \n",
       "...                                                ...                 ...   \n",
       "2524  https://www.clinicaltrials.gov/study/NCT06327490  NOT_YET_RECRUITING   \n",
       "2525  https://www.clinicaltrials.gov/study/NCT04314401          RECRUITING   \n",
       "2526  https://www.clinicaltrials.gov/study/NCT04472845          RECRUITING   \n",
       "2527  https://www.clinicaltrials.gov/study/NCT05536128  NOT_YET_RECRUITING   \n",
       "2528  https://www.clinicaltrials.gov/study/NCT05403554          RECRUITING   \n",
       "\n",
       "                                             CONDITIONS      PHASES  \\\n",
       "0                          ['Metastatic Breast Cancer']         NaN   \n",
       "1     ['Early-stage Breast Cancer', 'Estrogen-recept...  ['PHASE2']   \n",
       "2         ['Breast Cancer', 'Metastatic Breast Cancer']  ['PHASE2']   \n",
       "3                              ['Breast Cancer Female']  ['PHASE2']   \n",
       "4     ['Non-small Cell Lung Cancer', 'Colorectal Can...         NaN   \n",
       "...                                                 ...         ...   \n",
       "2524                                  ['Breast Cancer']      ['NA']   \n",
       "2525  ['Acute Myeloid Leukemia', 'Anatomic Stage III...         NaN   \n",
       "2526  ['Breast Cancer', 'Hypofractionation', 'Radiot...      ['NA']   \n",
       "2527                         ['Advanced Breast Cancer']  ['PHASE2']   \n",
       "2528  ['Epithelial Ovarian Cancer', 'Triple Negative...  ['PHASE1']   \n",
       "\n",
       "                                              LOCATIONS  START_DATE  ...  \\\n",
       "0     [{'Location Facility': \"Institut de Cancérolog...     2014-07  ...   \n",
       "1     [{'Location Facility': 'Imane Bachir', 'Locati...  2024-02-20  ...   \n",
       "2     [{'Location Facility': 'Marone Cancer Center C...  2024-10-01  ...   \n",
       "3     [{'Location Facility': \"Guy's and St Thomas NH...  2022-11-21  ...   \n",
       "4     [{'Location Facility': 'Orchard Healthcare Res...  2023-10-25  ...   \n",
       "...                                                 ...         ...  ...   \n",
       "2524  [{'Location Facility': 'University of Florida'...     2024-06  ...   \n",
       "2525  [{'Location Facility': 'Kingman Regional Medic...  2020-11-11  ...   \n",
       "2526  [{'Location Facility': 'Budhi Singh Yadav', 'L...  2021-03-30  ...   \n",
       "2527  [{'Location Facility': 'Seoul National Univers...  2022-12-31  ...   \n",
       "2528  [{'Location Facility': 'Institut Curie', 'Loca...  2022-04-29  ...   \n",
       "\n",
       "     MAXIMUMAGE                                   POINT_OF_CONTACT PHASE  \\\n",
       "0           NaN  {'Name': None, 'Organization': None, 'Email': ...   NaN   \n",
       "1      70 Years  {'Name': None, 'Organization': None, 'Email': ...   NaN   \n",
       "2           NaN  {'Name': None, 'Organization': None, 'Email': ...   NaN   \n",
       "3           NaN  {'Name': None, 'Organization': None, 'Email': ...   NaN   \n",
       "4           NaN  {'Name': None, 'Organization': None, 'Email': ...   NaN   \n",
       "...         ...                                                ...   ...   \n",
       "2524   99 Years  {'Name': None, 'Organization': None, 'Email': ...   NaN   \n",
       "2525        NaN  {'Name': None, 'Organization': None, 'Email': ...   NaN   \n",
       "2526        NaN  {'Name': None, 'Organization': None, 'Email': ...   NaN   \n",
       "2527        NaN  {'Name': None, 'Organization': None, 'Email': ...   NaN   \n",
       "2528        NaN  {'Name': None, 'Organization': None, 'Email': ...   NaN   \n",
       "\n",
       "         SEX                               ELIGIBILITY_CRITERIA  \\\n",
       "0        ALL  Eligibility includes patients who are 18 years...   \n",
       "1     FEMALE  Eligibility includes women aged 18-70 with a w...   \n",
       "2        ALL  Eligibility includes individuals 18 years or o...   \n",
       "3     FEMALE  Eligibility includes female subjects aged 18 o...   \n",
       "4        ALL  Eligibility includes patients who will be trea...   \n",
       "...      ...                                                ...   \n",
       "2524     ALL  Eligibility includes adults ≥18 years undergoi...   \n",
       "2525     ALL  Eligibility includes patients diagnosed or con...   \n",
       "2526  FEMALE  Eligibility includes individuals aged 18 or ol...   \n",
       "2527     ALL  Eligibility includes adults 19+ with HR+/HER2-...   \n",
       "2528     ALL  Eligibility includes adults ≥18 years with his...   \n",
       "\n",
       "                                       PRIMARY_OUTCOMES  \\\n",
       "0     The primary outcome is to describe the evoluti...   \n",
       "1     Primary outcomes focus on the perioperative pe...   \n",
       "2     The primary outcome measure is the Objective R...   \n",
       "3     The primary outcome is the margin status of wi...   \n",
       "4     The primary outcome is the sensitivity of ctDN...   \n",
       "...                                                 ...   \n",
       "2524  The primary outcome is to determine subject co...   \n",
       "2525  The primary outcomes involve procuring, storin...   \n",
       "2526  The primary outcome measure is loco-regional r...   \n",
       "2527  The primary outcome is the 6-month progression...   \n",
       "2528  Primary outcomes focus on safety and dosage, i...   \n",
       "\n",
       "                                     SECONDARY_OUTCOMES  \\\n",
       "0     Secondary outcomes aim to describe the impact ...   \n",
       "1     Secondary outcomes include changes in anxiety ...   \n",
       "2     Secondary outcomes include Progression Free Su...   \n",
       "3     Secondary outcomes include the agreement betwe...   \n",
       "4     Secondary outcomes include RECIST v1.1 respons...   \n",
       "...                                                 ...   \n",
       "2524  Secondary outcomes include comparing relative ...   \n",
       "2525  Secondary outcomes focus on pan-cancer gene pa...   \n",
       "2526  Secondary outcomes include disease-free surviv...   \n",
       "2527  Secondary outcomes include progression-free su...   \n",
       "2528  Secondary outcomes measure efficacy and pharma...   \n",
       "\n",
       "                                          INTERVENTIONS      STUDY_TYPE  \\\n",
       "0     The study does not specify interventions as it...   OBSERVATIONAL   \n",
       "1     The study involves four experimental arms: no ...  INTERVENTIONAL   \n",
       "2     The intervention involves administering Taletr...  INTERVENTIONAL   \n",
       "3     The intervention involves intraoperative Ceren...  INTERVENTIONAL   \n",
       "4     Interventions involve the collection of blood ...   OBSERVATIONAL   \n",
       "...                                                 ...             ...   \n",
       "2524  The study compares two types of manual lymphat...  INTERVENTIONAL   \n",
       "2525  Interventions include the collection of tissue...   OBSERVATIONAL   \n",
       "2526  The study involves two arms: the experimental ...  INTERVENTIONAL   \n",
       "2527  The study involves administering Olaparib tabl...  INTERVENTIONAL   \n",
       "2528  The intervention involves administering NI-180...  INTERVENTIONAL   \n",
       "\n",
       "     ENROLLMENT  \n",
       "0         38000  \n",
       "1           112  \n",
       "2            61  \n",
       "3            60  \n",
       "4           440  \n",
       "...         ...  \n",
       "2524         30  \n",
       "2525       1000  \n",
       "2526       1018  \n",
       "2527         64  \n",
       "2528         40  \n",
       "\n",
       "[2529 rows x 22 columns]"
      ]
     },
     "execution_count": 1,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "import pandas as pd\n",
    "df = pd.read_csv('/Users/suryabhosale/Documents/projects/DORIS/src/dorisclinicaltrials/ct_csv/CT_CSV_17_05.csv')\n",
    "df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "metadata": {},
   "outputs": [],
   "source": [
    "def get_zip_list(row):\n",
    "    zip_list = []\n",
    "    for loc_item in eval(row):\n",
    "        if loc_item['Location Zip']:\n",
    "            zip_list.append(loc_item['Location Zip'])\n",
    "    zip_str = ' '.join(zip_list)\n",
    "    return zip_str"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0       49933 33076 14076 63011 21079 59020 69373 1327...\n",
       "1                                                    1170\n",
       "2                                             33331 44195\n",
       "3                                                  SE19RT\n",
       "4                                              60077-1384\n",
       "                              ...                        \n",
       "2524                                                32610\n",
       "2525    86401 72903 93420 19901 19963 30342 31405 6170...\n",
       "2526                                               160012\n",
       "2527                                                     \n",
       "2528                  75005 75015 35042 20089 20141 37134\n",
       "Name: ZIP_STR, Length: 2529, dtype: object"
      ]
     },
     "execution_count": 31,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df['ZIP_STR'] = df.LOCATIONS.apply(lambda x: get_zip_list(x))\n",
    "df['ZIP_STR']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 54,
   "metadata": {},
   "outputs": [],
   "source": [
    "df.to_csv('../ct_csv/CT_CSV_22_05.csv')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 50,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Unnamed: 0.2</th>\n",
       "      <th>Unnamed: 0.1</th>\n",
       "      <th>Unnamed: 0</th>\n",
       "      <th>NCT_NUMBER</th>\n",
       "      <th>STUDY_TITLE</th>\n",
       "      <th>STUDY_URL</th>\n",
       "      <th>STUDY_STATUS</th>\n",
       "      <th>CONDITIONS</th>\n",
       "      <th>PHASES</th>\n",
       "      <th>LOCATIONS</th>\n",
       "      <th>...</th>\n",
       "      <th>PHASE</th>\n",
       "      <th>SEX</th>\n",
       "      <th>ELIGIBILITY_CRITERIA</th>\n",
       "      <th>PRIMARY_OUTCOMES</th>\n",
       "      <th>SECONDARY_OUTCOMES</th>\n",
       "      <th>INTERVENTIONS</th>\n",
       "      <th>STUDY_TYPE</th>\n",
       "      <th>ENROLLMENT</th>\n",
       "      <th>Zip Codes</th>\n",
       "      <th>ZIP_STR</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>NCT03275311</td>\n",
       "      <td>Evolution of the Therapeutic Care in Metastati...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT03275311</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>['Metastatic Breast Cancer']</td>\n",
       "      <td>NaN</td>\n",
       "      <td>[{'Location Facility': \"Institut de Cancérolog...</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>Eligibility includes patients who are 18 years...</td>\n",
       "      <td>The primary outcome is to describe the evoluti...</td>\n",
       "      <td>Secondary outcomes aim to describe the impact ...</td>\n",
       "      <td>The study does not specify interventions as it...</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>38000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>49933 33076 14076 63011 21079 59020 69373 1327...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>NCT06150898</td>\n",
       "      <td>Ketorolac and Pregabalin Effects on breaSt Can...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT06150898</td>\n",
       "      <td>NOT_YET_RECRUITING</td>\n",
       "      <td>['Early-stage Breast Cancer', 'Estrogen-recept...</td>\n",
       "      <td>['PHASE2']</td>\n",
       "      <td>[{'Location Facility': 'Imane Bachir', 'Locati...</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>FEMALE</td>\n",
       "      <td>Eligibility includes women aged 18-70 with a w...</td>\n",
       "      <td>Primary outcomes focus on the perioperative pe...</td>\n",
       "      <td>Secondary outcomes include changes in anxiety ...</td>\n",
       "      <td>The study involves four experimental arms: no ...</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>112</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1170</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>2</td>\n",
       "      <td>2</td>\n",
       "      <td>2</td>\n",
       "      <td>NCT06214793</td>\n",
       "      <td>Taletrectinib in Previously Treated Metastatic...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT06214793</td>\n",
       "      <td>NOT_YET_RECRUITING</td>\n",
       "      <td>['Breast Cancer', 'Metastatic Breast Cancer']</td>\n",
       "      <td>['PHASE2']</td>\n",
       "      <td>[{'Location Facility': 'Marone Cancer Center C...</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>Eligibility includes individuals 18 years or o...</td>\n",
       "      <td>The primary outcome measure is the Objective R...</td>\n",
       "      <td>Secondary outcomes include Progression Free Su...</td>\n",
       "      <td>The intervention involves administering Taletr...</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>61</td>\n",
       "      <td>NaN</td>\n",
       "      <td>33331 44195</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>3</td>\n",
       "      <td>3</td>\n",
       "      <td>3</td>\n",
       "      <td>NCT05496101</td>\n",
       "      <td>CLI and FAR for Intraoperative Margin Assessment</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT05496101</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>['Breast Cancer Female']</td>\n",
       "      <td>['PHASE2']</td>\n",
       "      <td>[{'Location Facility': \"Guy's and St Thomas NH...</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>FEMALE</td>\n",
       "      <td>Eligibility includes female subjects aged 18 o...</td>\n",
       "      <td>The primary outcome is the margin status of wi...</td>\n",
       "      <td>Secondary outcomes include the agreement betwe...</td>\n",
       "      <td>The intervention involves intraoperative Ceren...</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>60</td>\n",
       "      <td>NaN</td>\n",
       "      <td>SE19RT</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>4</td>\n",
       "      <td>4</td>\n",
       "      <td>4</td>\n",
       "      <td>NCT05935384</td>\n",
       "      <td>SIBYL: obServation of Therapy Response With lI...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT05935384</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>['Non-small Cell Lung Cancer', 'Colorectal Can...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>[{'Location Facility': 'Orchard Healthcare Res...</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>Eligibility includes patients who will be trea...</td>\n",
       "      <td>The primary outcome is the sensitivity of ctDN...</td>\n",
       "      <td>Secondary outcomes include RECIST v1.1 respons...</td>\n",
       "      <td>Interventions involve the collection of blood ...</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>440</td>\n",
       "      <td>NaN</td>\n",
       "      <td>60077-1384</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2524</th>\n",
       "      <td>2524</td>\n",
       "      <td>2524</td>\n",
       "      <td>2524</td>\n",
       "      <td>NCT06327490</td>\n",
       "      <td>A Study Evaluating the Feasibility and Complia...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT06327490</td>\n",
       "      <td>NOT_YET_RECRUITING</td>\n",
       "      <td>['Breast Cancer']</td>\n",
       "      <td>['NA']</td>\n",
       "      <td>[{'Location Facility': 'University of Florida'...</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>Eligibility includes adults ≥18 years undergoi...</td>\n",
       "      <td>The primary outcome is to determine subject co...</td>\n",
       "      <td>Secondary outcomes include comparing relative ...</td>\n",
       "      <td>The study compares two types of manual lymphat...</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>30</td>\n",
       "      <td>NaN</td>\n",
       "      <td>32610</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2525</th>\n",
       "      <td>2525</td>\n",
       "      <td>2525</td>\n",
       "      <td>2525</td>\n",
       "      <td>NCT04314401</td>\n",
       "      <td>National Cancer Institute \"Cancer Moonshot Bio...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT04314401</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>['Acute Myeloid Leukemia', 'Anatomic Stage III...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>[{'Location Facility': 'Kingman Regional Medic...</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>Eligibility includes patients diagnosed or con...</td>\n",
       "      <td>The primary outcomes involve procuring, storin...</td>\n",
       "      <td>Secondary outcomes focus on pan-cancer gene pa...</td>\n",
       "      <td>Interventions include the collection of tissue...</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>1000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>86401 72903 93420 19901 19963 30342 31405 6170...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2526</th>\n",
       "      <td>2526</td>\n",
       "      <td>2526</td>\n",
       "      <td>2526</td>\n",
       "      <td>NCT04472845</td>\n",
       "      <td>HYPofractionated Adjuvant RadioTherapy in 1 Ve...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT04472845</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>['Breast Cancer', 'Hypofractionation', 'Radiot...</td>\n",
       "      <td>['NA']</td>\n",
       "      <td>[{'Location Facility': 'Budhi Singh Yadav', 'L...</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>FEMALE</td>\n",
       "      <td>Eligibility includes individuals aged 18 or ol...</td>\n",
       "      <td>The primary outcome measure is loco-regional r...</td>\n",
       "      <td>Secondary outcomes include disease-free surviv...</td>\n",
       "      <td>The study involves two arms: the experimental ...</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>1018</td>\n",
       "      <td>NaN</td>\n",
       "      <td>160012</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2527</th>\n",
       "      <td>2527</td>\n",
       "      <td>2527</td>\n",
       "      <td>2527</td>\n",
       "      <td>NCT05536128</td>\n",
       "      <td>Evaluating the Efficacy and Safety of Fulvestr...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT05536128</td>\n",
       "      <td>NOT_YET_RECRUITING</td>\n",
       "      <td>['Advanced Breast Cancer']</td>\n",
       "      <td>['PHASE2']</td>\n",
       "      <td>[{'Location Facility': 'Seoul National Univers...</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>Eligibility includes adults 19+ with HR+/HER2-...</td>\n",
       "      <td>The primary outcome is the 6-month progression...</td>\n",
       "      <td>Secondary outcomes include progression-free su...</td>\n",
       "      <td>The study involves administering Olaparib tabl...</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>64</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2528</th>\n",
       "      <td>2528</td>\n",
       "      <td>2528</td>\n",
       "      <td>2528</td>\n",
       "      <td>NCT05403554</td>\n",
       "      <td>A Study of NI-1801 in Patients With Mesothelin...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT05403554</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>['Epithelial Ovarian Cancer', 'Triple Negative...</td>\n",
       "      <td>['PHASE1']</td>\n",
       "      <td>[{'Location Facility': 'Institut Curie', 'Loca...</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>Eligibility includes adults ≥18 years with his...</td>\n",
       "      <td>Primary outcomes focus on safety and dosage, i...</td>\n",
       "      <td>Secondary outcomes measure efficacy and pharma...</td>\n",
       "      <td>The intervention involves administering NI-180...</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>40</td>\n",
       "      <td>NaN</td>\n",
       "      <td>75005 75015 35042 20089 20141 37134</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>2529 rows × 25 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "      Unnamed: 0.2  Unnamed: 0.1  Unnamed: 0   NCT_NUMBER  \\\n",
       "0                0             0           0  NCT03275311   \n",
       "1                1             1           1  NCT06150898   \n",
       "2                2             2           2  NCT06214793   \n",
       "3                3             3           3  NCT05496101   \n",
       "4                4             4           4  NCT05935384   \n",
       "...            ...           ...         ...          ...   \n",
       "2524          2524          2524        2524  NCT06327490   \n",
       "2525          2525          2525        2525  NCT04314401   \n",
       "2526          2526          2526        2526  NCT04472845   \n",
       "2527          2527          2527        2527  NCT05536128   \n",
       "2528          2528          2528        2528  NCT05403554   \n",
       "\n",
       "                                            STUDY_TITLE  \\\n",
       "0     Evolution of the Therapeutic Care in Metastati...   \n",
       "1     Ketorolac and Pregabalin Effects on breaSt Can...   \n",
       "2     Taletrectinib in Previously Treated Metastatic...   \n",
       "3      CLI and FAR for Intraoperative Margin Assessment   \n",
       "4     SIBYL: obServation of Therapy Response With lI...   \n",
       "...                                                 ...   \n",
       "2524  A Study Evaluating the Feasibility and Complia...   \n",
       "2525  National Cancer Institute \"Cancer Moonshot Bio...   \n",
       "2526  HYPofractionated Adjuvant RadioTherapy in 1 Ve...   \n",
       "2527  Evaluating the Efficacy and Safety of Fulvestr...   \n",
       "2528  A Study of NI-1801 in Patients With Mesothelin...   \n",
       "\n",
       "                                             STUDY_URL        STUDY_STATUS  \\\n",
       "0     https://www.clinicaltrials.gov/study/NCT03275311          RECRUITING   \n",
       "1     https://www.clinicaltrials.gov/study/NCT06150898  NOT_YET_RECRUITING   \n",
       "2     https://www.clinicaltrials.gov/study/NCT06214793  NOT_YET_RECRUITING   \n",
       "3     https://www.clinicaltrials.gov/study/NCT05496101          RECRUITING   \n",
       "4     https://www.clinicaltrials.gov/study/NCT05935384          RECRUITING   \n",
       "...                                                ...                 ...   \n",
       "2524  https://www.clinicaltrials.gov/study/NCT06327490  NOT_YET_RECRUITING   \n",
       "2525  https://www.clinicaltrials.gov/study/NCT04314401          RECRUITING   \n",
       "2526  https://www.clinicaltrials.gov/study/NCT04472845          RECRUITING   \n",
       "2527  https://www.clinicaltrials.gov/study/NCT05536128  NOT_YET_RECRUITING   \n",
       "2528  https://www.clinicaltrials.gov/study/NCT05403554          RECRUITING   \n",
       "\n",
       "                                             CONDITIONS      PHASES  \\\n",
       "0                          ['Metastatic Breast Cancer']         NaN   \n",
       "1     ['Early-stage Breast Cancer', 'Estrogen-recept...  ['PHASE2']   \n",
       "2         ['Breast Cancer', 'Metastatic Breast Cancer']  ['PHASE2']   \n",
       "3                              ['Breast Cancer Female']  ['PHASE2']   \n",
       "4     ['Non-small Cell Lung Cancer', 'Colorectal Can...         NaN   \n",
       "...                                                 ...         ...   \n",
       "2524                                  ['Breast Cancer']      ['NA']   \n",
       "2525  ['Acute Myeloid Leukemia', 'Anatomic Stage III...         NaN   \n",
       "2526  ['Breast Cancer', 'Hypofractionation', 'Radiot...      ['NA']   \n",
       "2527                         ['Advanced Breast Cancer']  ['PHASE2']   \n",
       "2528  ['Epithelial Ovarian Cancer', 'Triple Negative...  ['PHASE1']   \n",
       "\n",
       "                                              LOCATIONS  ... PHASE     SEX  \\\n",
       "0     [{'Location Facility': \"Institut de Cancérolog...  ...   NaN     ALL   \n",
       "1     [{'Location Facility': 'Imane Bachir', 'Locati...  ...   NaN  FEMALE   \n",
       "2     [{'Location Facility': 'Marone Cancer Center C...  ...   NaN     ALL   \n",
       "3     [{'Location Facility': \"Guy's and St Thomas NH...  ...   NaN  FEMALE   \n",
       "4     [{'Location Facility': 'Orchard Healthcare Res...  ...   NaN     ALL   \n",
       "...                                                 ...  ...   ...     ...   \n",
       "2524  [{'Location Facility': 'University of Florida'...  ...   NaN     ALL   \n",
       "2525  [{'Location Facility': 'Kingman Regional Medic...  ...   NaN     ALL   \n",
       "2526  [{'Location Facility': 'Budhi Singh Yadav', 'L...  ...   NaN  FEMALE   \n",
       "2527  [{'Location Facility': 'Seoul National Univers...  ...   NaN     ALL   \n",
       "2528  [{'Location Facility': 'Institut Curie', 'Loca...  ...   NaN     ALL   \n",
       "\n",
       "                                   ELIGIBILITY_CRITERIA  \\\n",
       "0     Eligibility includes patients who are 18 years...   \n",
       "1     Eligibility includes women aged 18-70 with a w...   \n",
       "2     Eligibility includes individuals 18 years or o...   \n",
       "3     Eligibility includes female subjects aged 18 o...   \n",
       "4     Eligibility includes patients who will be trea...   \n",
       "...                                                 ...   \n",
       "2524  Eligibility includes adults ≥18 years undergoi...   \n",
       "2525  Eligibility includes patients diagnosed or con...   \n",
       "2526  Eligibility includes individuals aged 18 or ol...   \n",
       "2527  Eligibility includes adults 19+ with HR+/HER2-...   \n",
       "2528  Eligibility includes adults ≥18 years with his...   \n",
       "\n",
       "                                       PRIMARY_OUTCOMES  \\\n",
       "0     The primary outcome is to describe the evoluti...   \n",
       "1     Primary outcomes focus on the perioperative pe...   \n",
       "2     The primary outcome measure is the Objective R...   \n",
       "3     The primary outcome is the margin status of wi...   \n",
       "4     The primary outcome is the sensitivity of ctDN...   \n",
       "...                                                 ...   \n",
       "2524  The primary outcome is to determine subject co...   \n",
       "2525  The primary outcomes involve procuring, storin...   \n",
       "2526  The primary outcome measure is loco-regional r...   \n",
       "2527  The primary outcome is the 6-month progression...   \n",
       "2528  Primary outcomes focus on safety and dosage, i...   \n",
       "\n",
       "                                     SECONDARY_OUTCOMES  \\\n",
       "0     Secondary outcomes aim to describe the impact ...   \n",
       "1     Secondary outcomes include changes in anxiety ...   \n",
       "2     Secondary outcomes include Progression Free Su...   \n",
       "3     Secondary outcomes include the agreement betwe...   \n",
       "4     Secondary outcomes include RECIST v1.1 respons...   \n",
       "...                                                 ...   \n",
       "2524  Secondary outcomes include comparing relative ...   \n",
       "2525  Secondary outcomes focus on pan-cancer gene pa...   \n",
       "2526  Secondary outcomes include disease-free surviv...   \n",
       "2527  Secondary outcomes include progression-free su...   \n",
       "2528  Secondary outcomes measure efficacy and pharma...   \n",
       "\n",
       "                                          INTERVENTIONS      STUDY_TYPE  \\\n",
       "0     The study does not specify interventions as it...   OBSERVATIONAL   \n",
       "1     The study involves four experimental arms: no ...  INTERVENTIONAL   \n",
       "2     The intervention involves administering Taletr...  INTERVENTIONAL   \n",
       "3     The intervention involves intraoperative Ceren...  INTERVENTIONAL   \n",
       "4     Interventions involve the collection of blood ...   OBSERVATIONAL   \n",
       "...                                                 ...             ...   \n",
       "2524  The study compares two types of manual lymphat...  INTERVENTIONAL   \n",
       "2525  Interventions include the collection of tissue...   OBSERVATIONAL   \n",
       "2526  The study involves two arms: the experimental ...  INTERVENTIONAL   \n",
       "2527  The study involves administering Olaparib tabl...  INTERVENTIONAL   \n",
       "2528  The intervention involves administering NI-180...  INTERVENTIONAL   \n",
       "\n",
       "     ENROLLMENT Zip Codes                                            ZIP_STR  \n",
       "0         38000       NaN  49933 33076 14076 63011 21079 59020 69373 1327...  \n",
       "1           112       NaN                                               1170  \n",
       "2            61       NaN                                        33331 44195  \n",
       "3            60       NaN                                             SE19RT  \n",
       "4           440       NaN                                         60077-1384  \n",
       "...         ...       ...                                                ...  \n",
       "2524         30       NaN                                              32610  \n",
       "2525       1000       NaN  86401 72903 93420 19901 19963 30342 31405 6170...  \n",
       "2526       1018       NaN                                             160012  \n",
       "2527         64       NaN                                                NaN  \n",
       "2528         40       NaN                75005 75015 35042 20089 20141 37134  \n",
       "\n",
       "[2529 rows x 25 columns]"
      ]
     },
     "execution_count": 50,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df = pd.read_csv('../ct_csv/CT_CSV_22_05.csv')\n",
    "df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 52,
   "metadata": {},
   "outputs": [],
   "source": [
    "df.fillna('', inplace=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 53,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "str"
      ]
     },
     "execution_count": 53,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "type(df['ZIP_STR'].iloc[5])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 44,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0    49933 33076 14076 63011 21079 59020 69373 1327...\n",
       "1                                                 1170\n",
       "2                                          33331 44195\n",
       "3                                               SE19RT\n",
       "4                                           60077-1384\n",
       "5                                                     \n",
       "6                                                55905\n",
       "7                                          92210 92210\n",
       "8                                                94063\n",
       "9                                               450008\n",
       "Name: ZIP_STR, dtype: object"
      ]
     },
     "execution_count": 44,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df['ZIP_STR'].head(10)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "metadata": {},
   "outputs": [],
   "source": [
    "def contains_number(row, number):\n",
    "    return number in row.split()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 55,
   "metadata": {},
   "outputs": [],
   "source": [
    "nct_list = list(df[df['ZIP_STR'].apply(lambda x: contains_number(x, '60601'))]['NCT_NUMBER'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 56,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['NCT04821141', 'NCT05615753']"
      ]
     },
     "execution_count": 56,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "nct_list"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 57,
   "metadata": {},
   "outputs": [],
   "source": [
    "list1 = ['60918', '46524', '60924', '61047', '60962', '60973', '61063', '49061', '49065', '61326', '47929', '49067', '46975', '61337', '61054', '53069', '61377', '46507', '53092', '61321', '61775', '53538', '53066', '47926', '46950', '61024', '46526', '53097', '53137', '61740', '61021', '49055', '61335', '53022', '53017', '47921', '46539', '47997', '61358', '47971', '60952', '46553', '46528', '49071', '47923', '47917', '61349', '53549', '61726', '53576', '61336', '53033', '46542', '60948', '61327', '61039', '53012', '61773', '53534', '60942', '49423', '61019', '49419', '61067', '46508', '53024', '61369', '61731', '60960', '53076']\n",
    "list2 = ['12345', '67890', '60918'] "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 60,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "True"
      ]
     },
     "execution_count": 60,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "not set(list1).isdisjoint(set(list2))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 59,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "True\n"
     ]
    }
   ],
   "source": [
    "def has_overlap(list1, list2):\n",
    "    # Convert lists to sets\n",
    "    set1 = set(list1)\n",
    "    set2 = set(list2)\n",
    "    \n",
    "    # Check for intersection\n",
    "    return not set1.isdisjoint(set2)\n",
    "\n",
    "# Example lists\n",
    "list1 = ['60918', '46524', '60924', '61047', '60962', '60973', '61063', '49061', '49065', '61326', '47929', '49067', '46975', '61337', '61054', '53069', '61377', '46507', '53092', '61321', '61775', '53538', '53066', '47926', '46950', '61024', '46526', '53097', '53137', '61740', '61021', '49055', '61335', '53022', '53017', '47921', '46539', '47997', '61358', '47971', '60952', '46553', '46528', '49071', '47923', '47917', '61349', '53549', '61726', '53576', '61336', '53033', '46542', '60948', '61327', '61039', '53012', '61773', '53534', '60942', '49423', '61019', '49419', '61067', '46508', '53024', '61369', '61731', '60960', '53076']\n",
    "list2 = ['12345', '67890', '60918']  # Example with overlap\n",
    "\n",
    "# Check for overlap\n",
    "print(has_overlap(list1, list2))  # Output: True"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 61,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Unnamed: 0.2</th>\n",
       "      <th>Unnamed: 0.1</th>\n",
       "      <th>Unnamed: 0</th>\n",
       "      <th>NCT_NUMBER</th>\n",
       "      <th>STUDY_TITLE</th>\n",
       "      <th>STUDY_URL</th>\n",
       "      <th>STUDY_STATUS</th>\n",
       "      <th>CONDITIONS</th>\n",
       "      <th>PHASES</th>\n",
       "      <th>LOCATIONS</th>\n",
       "      <th>...</th>\n",
       "      <th>PHASE</th>\n",
       "      <th>SEX</th>\n",
       "      <th>ELIGIBILITY_CRITERIA</th>\n",
       "      <th>PRIMARY_OUTCOMES</th>\n",
       "      <th>SECONDARY_OUTCOMES</th>\n",
       "      <th>INTERVENTIONS</th>\n",
       "      <th>STUDY_TYPE</th>\n",
       "      <th>ENROLLMENT</th>\n",
       "      <th>Zip Codes</th>\n",
       "      <th>ZIP_STR</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>NCT03275311</td>\n",
       "      <td>Evolution of the Therapeutic Care in Metastati...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT03275311</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>['Metastatic Breast Cancer']</td>\n",
       "      <td></td>\n",
       "      <td>[{'Location Facility': \"Institut de Cancérolog...</td>\n",
       "      <td>...</td>\n",
       "      <td></td>\n",
       "      <td>ALL</td>\n",
       "      <td>Eligibility includes patients who are 18 years...</td>\n",
       "      <td>The primary outcome is to describe the evoluti...</td>\n",
       "      <td>Secondary outcomes aim to describe the impact ...</td>\n",
       "      <td>The study does not specify interventions as it...</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>38000</td>\n",
       "      <td></td>\n",
       "      <td>49933 33076 14076 63011 21079 59020 69373 1327...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>NCT06150898</td>\n",
       "      <td>Ketorolac and Pregabalin Effects on breaSt Can...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT06150898</td>\n",
       "      <td>NOT_YET_RECRUITING</td>\n",
       "      <td>['Early-stage Breast Cancer', 'Estrogen-recept...</td>\n",
       "      <td>['PHASE2']</td>\n",
       "      <td>[{'Location Facility': 'Imane Bachir', 'Locati...</td>\n",
       "      <td>...</td>\n",
       "      <td></td>\n",
       "      <td>FEMALE</td>\n",
       "      <td>Eligibility includes women aged 18-70 with a w...</td>\n",
       "      <td>Primary outcomes focus on the perioperative pe...</td>\n",
       "      <td>Secondary outcomes include changes in anxiety ...</td>\n",
       "      <td>The study involves four experimental arms: no ...</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>112</td>\n",
       "      <td></td>\n",
       "      <td>1170</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>2</td>\n",
       "      <td>2</td>\n",
       "      <td>2</td>\n",
       "      <td>NCT06214793</td>\n",
       "      <td>Taletrectinib in Previously Treated Metastatic...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT06214793</td>\n",
       "      <td>NOT_YET_RECRUITING</td>\n",
       "      <td>['Breast Cancer', 'Metastatic Breast Cancer']</td>\n",
       "      <td>['PHASE2']</td>\n",
       "      <td>[{'Location Facility': 'Marone Cancer Center C...</td>\n",
       "      <td>...</td>\n",
       "      <td></td>\n",
       "      <td>ALL</td>\n",
       "      <td>Eligibility includes individuals 18 years or o...</td>\n",
       "      <td>The primary outcome measure is the Objective R...</td>\n",
       "      <td>Secondary outcomes include Progression Free Su...</td>\n",
       "      <td>The intervention involves administering Taletr...</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>61</td>\n",
       "      <td></td>\n",
       "      <td>33331 44195</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>3</td>\n",
       "      <td>3</td>\n",
       "      <td>3</td>\n",
       "      <td>NCT05496101</td>\n",
       "      <td>CLI and FAR for Intraoperative Margin Assessment</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT05496101</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>['Breast Cancer Female']</td>\n",
       "      <td>['PHASE2']</td>\n",
       "      <td>[{'Location Facility': \"Guy's and St Thomas NH...</td>\n",
       "      <td>...</td>\n",
       "      <td></td>\n",
       "      <td>FEMALE</td>\n",
       "      <td>Eligibility includes female subjects aged 18 o...</td>\n",
       "      <td>The primary outcome is the margin status of wi...</td>\n",
       "      <td>Secondary outcomes include the agreement betwe...</td>\n",
       "      <td>The intervention involves intraoperative Ceren...</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>60</td>\n",
       "      <td></td>\n",
       "      <td>SE19RT</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>4</td>\n",
       "      <td>4</td>\n",
       "      <td>4</td>\n",
       "      <td>NCT05935384</td>\n",
       "      <td>SIBYL: obServation of Therapy Response With lI...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT05935384</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>['Non-small Cell Lung Cancer', 'Colorectal Can...</td>\n",
       "      <td></td>\n",
       "      <td>[{'Location Facility': 'Orchard Healthcare Res...</td>\n",
       "      <td>...</td>\n",
       "      <td></td>\n",
       "      <td>ALL</td>\n",
       "      <td>Eligibility includes patients who will be trea...</td>\n",
       "      <td>The primary outcome is the sensitivity of ctDN...</td>\n",
       "      <td>Secondary outcomes include RECIST v1.1 respons...</td>\n",
       "      <td>Interventions involve the collection of blood ...</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>440</td>\n",
       "      <td></td>\n",
       "      <td>60077-1384</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2524</th>\n",
       "      <td>2524</td>\n",
       "      <td>2524</td>\n",
       "      <td>2524</td>\n",
       "      <td>NCT06327490</td>\n",
       "      <td>A Study Evaluating the Feasibility and Complia...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT06327490</td>\n",
       "      <td>NOT_YET_RECRUITING</td>\n",
       "      <td>['Breast Cancer']</td>\n",
       "      <td>['NA']</td>\n",
       "      <td>[{'Location Facility': 'University of Florida'...</td>\n",
       "      <td>...</td>\n",
       "      <td></td>\n",
       "      <td>ALL</td>\n",
       "      <td>Eligibility includes adults ≥18 years undergoi...</td>\n",
       "      <td>The primary outcome is to determine subject co...</td>\n",
       "      <td>Secondary outcomes include comparing relative ...</td>\n",
       "      <td>The study compares two types of manual lymphat...</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>30</td>\n",
       "      <td></td>\n",
       "      <td>32610</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2525</th>\n",
       "      <td>2525</td>\n",
       "      <td>2525</td>\n",
       "      <td>2525</td>\n",
       "      <td>NCT04314401</td>\n",
       "      <td>National Cancer Institute \"Cancer Moonshot Bio...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT04314401</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>['Acute Myeloid Leukemia', 'Anatomic Stage III...</td>\n",
       "      <td></td>\n",
       "      <td>[{'Location Facility': 'Kingman Regional Medic...</td>\n",
       "      <td>...</td>\n",
       "      <td></td>\n",
       "      <td>ALL</td>\n",
       "      <td>Eligibility includes patients diagnosed or con...</td>\n",
       "      <td>The primary outcomes involve procuring, storin...</td>\n",
       "      <td>Secondary outcomes focus on pan-cancer gene pa...</td>\n",
       "      <td>Interventions include the collection of tissue...</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>1000</td>\n",
       "      <td></td>\n",
       "      <td>86401 72903 93420 19901 19963 30342 31405 6170...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2526</th>\n",
       "      <td>2526</td>\n",
       "      <td>2526</td>\n",
       "      <td>2526</td>\n",
       "      <td>NCT04472845</td>\n",
       "      <td>HYPofractionated Adjuvant RadioTherapy in 1 Ve...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT04472845</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>['Breast Cancer', 'Hypofractionation', 'Radiot...</td>\n",
       "      <td>['NA']</td>\n",
       "      <td>[{'Location Facility': 'Budhi Singh Yadav', 'L...</td>\n",
       "      <td>...</td>\n",
       "      <td></td>\n",
       "      <td>FEMALE</td>\n",
       "      <td>Eligibility includes individuals aged 18 or ol...</td>\n",
       "      <td>The primary outcome measure is loco-regional r...</td>\n",
       "      <td>Secondary outcomes include disease-free surviv...</td>\n",
       "      <td>The study involves two arms: the experimental ...</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>1018</td>\n",
       "      <td></td>\n",
       "      <td>160012</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2527</th>\n",
       "      <td>2527</td>\n",
       "      <td>2527</td>\n",
       "      <td>2527</td>\n",
       "      <td>NCT05536128</td>\n",
       "      <td>Evaluating the Efficacy and Safety of Fulvestr...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT05536128</td>\n",
       "      <td>NOT_YET_RECRUITING</td>\n",
       "      <td>['Advanced Breast Cancer']</td>\n",
       "      <td>['PHASE2']</td>\n",
       "      <td>[{'Location Facility': 'Seoul National Univers...</td>\n",
       "      <td>...</td>\n",
       "      <td></td>\n",
       "      <td>ALL</td>\n",
       "      <td>Eligibility includes adults 19+ with HR+/HER2-...</td>\n",
       "      <td>The primary outcome is the 6-month progression...</td>\n",
       "      <td>Secondary outcomes include progression-free su...</td>\n",
       "      <td>The study involves administering Olaparib tabl...</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>64</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2528</th>\n",
       "      <td>2528</td>\n",
       "      <td>2528</td>\n",
       "      <td>2528</td>\n",
       "      <td>NCT05403554</td>\n",
       "      <td>A Study of NI-1801 in Patients With Mesothelin...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT05403554</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>['Epithelial Ovarian Cancer', 'Triple Negative...</td>\n",
       "      <td>['PHASE1']</td>\n",
       "      <td>[{'Location Facility': 'Institut Curie', 'Loca...</td>\n",
       "      <td>...</td>\n",
       "      <td></td>\n",
       "      <td>ALL</td>\n",
       "      <td>Eligibility includes adults ≥18 years with his...</td>\n",
       "      <td>Primary outcomes focus on safety and dosage, i...</td>\n",
       "      <td>Secondary outcomes measure efficacy and pharma...</td>\n",
       "      <td>The intervention involves administering NI-180...</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>40</td>\n",
       "      <td></td>\n",
       "      <td>75005 75015 35042 20089 20141 37134</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>2529 rows × 25 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "      Unnamed: 0.2  Unnamed: 0.1  Unnamed: 0   NCT_NUMBER  \\\n",
       "0                0             0           0  NCT03275311   \n",
       "1                1             1           1  NCT06150898   \n",
       "2                2             2           2  NCT06214793   \n",
       "3                3             3           3  NCT05496101   \n",
       "4                4             4           4  NCT05935384   \n",
       "...            ...           ...         ...          ...   \n",
       "2524          2524          2524        2524  NCT06327490   \n",
       "2525          2525          2525        2525  NCT04314401   \n",
       "2526          2526          2526        2526  NCT04472845   \n",
       "2527          2527          2527        2527  NCT05536128   \n",
       "2528          2528          2528        2528  NCT05403554   \n",
       "\n",
       "                                            STUDY_TITLE  \\\n",
       "0     Evolution of the Therapeutic Care in Metastati...   \n",
       "1     Ketorolac and Pregabalin Effects on breaSt Can...   \n",
       "2     Taletrectinib in Previously Treated Metastatic...   \n",
       "3      CLI and FAR for Intraoperative Margin Assessment   \n",
       "4     SIBYL: obServation of Therapy Response With lI...   \n",
       "...                                                 ...   \n",
       "2524  A Study Evaluating the Feasibility and Complia...   \n",
       "2525  National Cancer Institute \"Cancer Moonshot Bio...   \n",
       "2526  HYPofractionated Adjuvant RadioTherapy in 1 Ve...   \n",
       "2527  Evaluating the Efficacy and Safety of Fulvestr...   \n",
       "2528  A Study of NI-1801 in Patients With Mesothelin...   \n",
       "\n",
       "                                             STUDY_URL        STUDY_STATUS  \\\n",
       "0     https://www.clinicaltrials.gov/study/NCT03275311          RECRUITING   \n",
       "1     https://www.clinicaltrials.gov/study/NCT06150898  NOT_YET_RECRUITING   \n",
       "2     https://www.clinicaltrials.gov/study/NCT06214793  NOT_YET_RECRUITING   \n",
       "3     https://www.clinicaltrials.gov/study/NCT05496101          RECRUITING   \n",
       "4     https://www.clinicaltrials.gov/study/NCT05935384          RECRUITING   \n",
       "...                                                ...                 ...   \n",
       "2524  https://www.clinicaltrials.gov/study/NCT06327490  NOT_YET_RECRUITING   \n",
       "2525  https://www.clinicaltrials.gov/study/NCT04314401          RECRUITING   \n",
       "2526  https://www.clinicaltrials.gov/study/NCT04472845          RECRUITING   \n",
       "2527  https://www.clinicaltrials.gov/study/NCT05536128  NOT_YET_RECRUITING   \n",
       "2528  https://www.clinicaltrials.gov/study/NCT05403554          RECRUITING   \n",
       "\n",
       "                                             CONDITIONS      PHASES  \\\n",
       "0                          ['Metastatic Breast Cancer']               \n",
       "1     ['Early-stage Breast Cancer', 'Estrogen-recept...  ['PHASE2']   \n",
       "2         ['Breast Cancer', 'Metastatic Breast Cancer']  ['PHASE2']   \n",
       "3                              ['Breast Cancer Female']  ['PHASE2']   \n",
       "4     ['Non-small Cell Lung Cancer', 'Colorectal Can...               \n",
       "...                                                 ...         ...   \n",
       "2524                                  ['Breast Cancer']      ['NA']   \n",
       "2525  ['Acute Myeloid Leukemia', 'Anatomic Stage III...               \n",
       "2526  ['Breast Cancer', 'Hypofractionation', 'Radiot...      ['NA']   \n",
       "2527                         ['Advanced Breast Cancer']  ['PHASE2']   \n",
       "2528  ['Epithelial Ovarian Cancer', 'Triple Negative...  ['PHASE1']   \n",
       "\n",
       "                                              LOCATIONS  ... PHASE     SEX  \\\n",
       "0     [{'Location Facility': \"Institut de Cancérolog...  ...           ALL   \n",
       "1     [{'Location Facility': 'Imane Bachir', 'Locati...  ...        FEMALE   \n",
       "2     [{'Location Facility': 'Marone Cancer Center C...  ...           ALL   \n",
       "3     [{'Location Facility': \"Guy's and St Thomas NH...  ...        FEMALE   \n",
       "4     [{'Location Facility': 'Orchard Healthcare Res...  ...           ALL   \n",
       "...                                                 ...  ...   ...     ...   \n",
       "2524  [{'Location Facility': 'University of Florida'...  ...           ALL   \n",
       "2525  [{'Location Facility': 'Kingman Regional Medic...  ...           ALL   \n",
       "2526  [{'Location Facility': 'Budhi Singh Yadav', 'L...  ...        FEMALE   \n",
       "2527  [{'Location Facility': 'Seoul National Univers...  ...           ALL   \n",
       "2528  [{'Location Facility': 'Institut Curie', 'Loca...  ...           ALL   \n",
       "\n",
       "                                   ELIGIBILITY_CRITERIA  \\\n",
       "0     Eligibility includes patients who are 18 years...   \n",
       "1     Eligibility includes women aged 18-70 with a w...   \n",
       "2     Eligibility includes individuals 18 years or o...   \n",
       "3     Eligibility includes female subjects aged 18 o...   \n",
       "4     Eligibility includes patients who will be trea...   \n",
       "...                                                 ...   \n",
       "2524  Eligibility includes adults ≥18 years undergoi...   \n",
       "2525  Eligibility includes patients diagnosed or con...   \n",
       "2526  Eligibility includes individuals aged 18 or ol...   \n",
       "2527  Eligibility includes adults 19+ with HR+/HER2-...   \n",
       "2528  Eligibility includes adults ≥18 years with his...   \n",
       "\n",
       "                                       PRIMARY_OUTCOMES  \\\n",
       "0     The primary outcome is to describe the evoluti...   \n",
       "1     Primary outcomes focus on the perioperative pe...   \n",
       "2     The primary outcome measure is the Objective R...   \n",
       "3     The primary outcome is the margin status of wi...   \n",
       "4     The primary outcome is the sensitivity of ctDN...   \n",
       "...                                                 ...   \n",
       "2524  The primary outcome is to determine subject co...   \n",
       "2525  The primary outcomes involve procuring, storin...   \n",
       "2526  The primary outcome measure is loco-regional r...   \n",
       "2527  The primary outcome is the 6-month progression...   \n",
       "2528  Primary outcomes focus on safety and dosage, i...   \n",
       "\n",
       "                                     SECONDARY_OUTCOMES  \\\n",
       "0     Secondary outcomes aim to describe the impact ...   \n",
       "1     Secondary outcomes include changes in anxiety ...   \n",
       "2     Secondary outcomes include Progression Free Su...   \n",
       "3     Secondary outcomes include the agreement betwe...   \n",
       "4     Secondary outcomes include RECIST v1.1 respons...   \n",
       "...                                                 ...   \n",
       "2524  Secondary outcomes include comparing relative ...   \n",
       "2525  Secondary outcomes focus on pan-cancer gene pa...   \n",
       "2526  Secondary outcomes include disease-free surviv...   \n",
       "2527  Secondary outcomes include progression-free su...   \n",
       "2528  Secondary outcomes measure efficacy and pharma...   \n",
       "\n",
       "                                          INTERVENTIONS      STUDY_TYPE  \\\n",
       "0     The study does not specify interventions as it...   OBSERVATIONAL   \n",
       "1     The study involves four experimental arms: no ...  INTERVENTIONAL   \n",
       "2     The intervention involves administering Taletr...  INTERVENTIONAL   \n",
       "3     The intervention involves intraoperative Ceren...  INTERVENTIONAL   \n",
       "4     Interventions involve the collection of blood ...   OBSERVATIONAL   \n",
       "...                                                 ...             ...   \n",
       "2524  The study compares two types of manual lymphat...  INTERVENTIONAL   \n",
       "2525  Interventions include the collection of tissue...   OBSERVATIONAL   \n",
       "2526  The study involves two arms: the experimental ...  INTERVENTIONAL   \n",
       "2527  The study involves administering Olaparib tabl...  INTERVENTIONAL   \n",
       "2528  The intervention involves administering NI-180...  INTERVENTIONAL   \n",
       "\n",
       "     ENROLLMENT Zip Codes                                            ZIP_STR  \n",
       "0         38000            49933 33076 14076 63011 21079 59020 69373 1327...  \n",
       "1           112                                                         1170  \n",
       "2            61                                                  33331 44195  \n",
       "3            60                                                       SE19RT  \n",
       "4           440                                                   60077-1384  \n",
       "...         ...       ...                                                ...  \n",
       "2524         30                                                        32610  \n",
       "2525       1000            86401 72903 93420 19901 19963 30342 31405 6170...  \n",
       "2526       1018                                                       160012  \n",
       "2527         64                                                               \n",
       "2528         40                          75005 75015 35042 20089 20141 37134  \n",
       "\n",
       "[2529 rows x 25 columns]"
      ]
     },
     "execution_count": 61,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "for i in df.ZIP_STR.apply(lambda x: eval(x) if x isinstance(x, str) else element)"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "langchain",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.9.16"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
